Redburn Atlantic Adjusts Amgen Price Target to $200 From $180, Maintains Sell Rating
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Amgen (AMGN) Gets a Buy From Jefferies
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Argus Research Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $360
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $381
Daiwa Securities Adjusts Price Target on Amgen to $351 From $350, Maintains Buy Rating
Redburn Atlantic Adjusts Amgen Price Target to $180 From $170, Maintains Sell Rating
HSBC Adjusts Price Target on Amgen to $369 From $356
RBC Capital raised Amgen's target price to $362.
Oppenheimer Maintains Outperform on Amgen, Maintains $380 Price Target
Amgen Price Target Cut to $305.00/Share From $310.00 by Deutsche Bank
B of A Securities Maintains Neutral on Amgen, Raises Price Target to $330
Amgen Analyst Ratings
Piper Sandler Releases a Buy Rating on Amgen (AMGN)
Wells Fargo Downgrades Amgen to Equalweight From Overweight, Adjusts Price Target to $335 From $320
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360